NCT05228951 2022-09-13
Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC
Shengjing Hospital
Phase 2 Recruiting
Shengjing Hospital
Shengjing Hospital
Servier
Dong Wha Pharmaceutical Co. Ltd.
University of Malaga